Company news
Alpha Tau Medical Ltd news in 2025
Alpha Tau Medical Ltd's news releases, calls and decks from 2025, newest first.
Alpha Tau to Present at the J.P. Morgan 2026 Healthcare Conference
December 18, 2025
Alpha Tau Successfully Treats First Patient in its U.S. Trial for Patients with Recurrent Glioblastoma at the James Cancer Hospital at The Ohio State University
December 9, 2025
Alpha Tau Announces Presentation of Two Alpha DaRT Pancreatic Cancer Abstracts at Upcoming 2026 ASCO GI Symposium
December 4, 2025
Alpha Tau Receives FDA Approval to Initiate a Trial for Patients with Locally Recurrent Prostate Cancer
December 2, 2025
Alpha Tau to Participate in December Investor Conferences
December 1, 2025
Alpha Tau Announces Third Quarter 2025 Financial Results and Provides Corporate Update
November 20, 2025
Alpha Tau to Participate at Jefferies Global Healthcare Conference in London
November 11, 2025
Alpha Tau Announces Receipt of Radioactive Material License for its New Hampshire Manufacturing Facility, Advancing Towards Commercial Readiness
October 21, 2025
Alpha Tau Successfully Treats First Patient in its U.S. Multi-Center Pancreatic Cancer Clinical Trial
September 2, 2025
Alpha Tau to Participate in Five September Investor Conferences
August 27, 2025
Alpha Tau Announces Second Quarter 2025 Financial Results and Provides Corporate Update
August 11, 2025
Alpha Tau to Present at Jefferies Global Healthcare Conference
May 28, 2025
Alpha Tau Announces First Quarter 2025 Financial Results and Provides Corporate Update
May 19, 2025
Alpha Tau Announces Appointment of Nadav Kidron to its Board of Directors
May 12, 2025
Alpha Tau to Participate in May Investor Conferences
May 6, 2025
Alpha Tau Announces Closing of $36.9 Million Registered Direct Offering and Strategic Marketing Alliance with Oramed Pharmaceuticals
April 28, 2025
Alpha Tau Receives FDA Approval to Initiate a Trial for Patients with Recurrent Glioblastoma
April 2, 2025
Alpha Tau Announces Full Year 2024 Financial Results and Provides Corporate Update
March 12, 2025
Alpha Tau to Participate in March Investor Conferences
February 27, 2025
Alpha Tau Receives Medical Device Single Audit Program (MDSAP) Certification
February 24, 2025
Decks in 2025
- Investor Day (January 2025)
Investor day · 84 slides · January 2025